Infertility Clinical Trial
Official title:
Oogonial Stem Cell Isolation in Ovarian Insufficiency Patients
Background:
- Primary ovarian insufficiency (POI) is a condition that affects ovary function. It means
that the ovaries are not able to function at a level appropriate for a woman's age.
Previously, it was thought that women had only a fixed number of eggs that were lost each
month until none were left at menopause. However, recently, stem cells have been found in the
ovaries of adult women. These stem cells may be able to make new eggs. Studying these cells
may help women with POI in the future. Researchers want to collect ovarian tissue from women
with POI to investigate ovarian stem cells.
Objectives:
- To collect ovarian tissue from women with primary ovarian insufficiency.
Eligibility:
- Women between 18 and 50 years of age with primary ovarian insufficiency.
Design:
- Participants will be screened with a physical exam and medical history. They will also
have a full gynecological exam. They will provide blood and urine samples.
- Participants will donate ovarian tissue for study. It will be collected through
outpatient surgery. The surgery will take either half of an ovary or a full ovary.
- Treatment will not be provided as part of this study.
Early loss of human ovarian function results in a clinical condition known as primary ovarian
insufficiency (POI) or premature ovarian failure (POF). This devastating condition renders
women unable to have their own genetic child in more than 95% of cases (1), as well as
failure of hormonal production by the ovary that is critical in maintaining bone health,
restful sleep, and quality of life. Indeed, in more carefully designed studies where control
groups were used, only 1.5% of POI patients became pregnant (2-8), which may more accurately
represent the true fertility rate in this population. Currently, fertility treatments for
these patients are primarily to use an egg donated from a young woman
Until recently, it was thought that women were born with a limited number of eggs, which were
slowly depleted each month until exhaustion at the time of menopause. However, recent studies
have suggested that new eggs can be made from adult stem cells in the ovary. (1, 2) These
ovarian stem cells could be transplanted into a recipient mouse, who then delivered donor
derived offspring (3). Recently, ovarian germline stem cell (i.e., oogonial stem cell)
isolation has been reported from human ovaries (12).(4). However, it is not known if oogonial
stem cell problems play a part in diseases such as premature ovarian failure or diminished
ovarian reserve.
The goal of this protocol is to characterize oogonial stem cells in patients with primary
ovarian insufficiency (POI)/failure (POF) and diminished ovarian reserve (DOR). There will be
three groups in this study: patients with POI or POF undergoing ovarian biopsy by
laparoscopy, patients with POI or POF undergoing clinically indicated abdominal surgery that
provides access to the ovaries, and patients over 18 undergoing clinically indicated ovarian
surgery (with or without POI or POF). Ovarian biopsies will be harvested by laparoscopy or at
the time of indicated surgery, and oogonial stem cells will be isolated in the laboratory and
characterized.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03607409 -
Role of Inhibin A as Biomarker for Ovarian Response for IVF Treatment
|
||
Recruiting |
NCT02312076 -
GnRHa for Luteal Phase Support in Long GnRHa Protocol Cycles
|
Phase 4 | |
Terminated |
NCT02161861 -
Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study
|
N/A | |
Completed |
NCT03287479 -
Comparison of a Semi-automated Closed Vitrification System (Gavi®) With a Manual Open Vitrification Sytem (Cryotop®)
|
N/A | |
Terminated |
NCT03522350 -
Randomized Trial Comparing EmbryoScope With EmbryoScope+.
|
N/A | |
Completed |
NCT04496284 -
Embryo Transfer Outcomes After Vitrification With Slush Nitrogen Compared to Liquid Nitrogen
|
N/A | |
Completed |
NCT03623659 -
pArtiaL zonA pelluciDa Removal by assisteD hatchINg of Blastocysts
|
N/A | |
Completed |
NCT03895099 -
New Ovarian Stimulation With Random Start, Use of Progestin Protocol for Oocyte Donors
|
Phase 3 | |
Active, not recruiting |
NCT04142112 -
Randomized, Standard-Controlled, Study to Evaluate the Ohana IVF Sperm Preparation Kit, SPeRtility IVF Next Generation
|
N/A | |
Completed |
NCT03152643 -
Cumulative Live Birth Rates After Cleavage-stage Versus Blastocyst-stage Embryo Transfer
|
N/A | |
Recruiting |
NCT03683771 -
Assessment of Endometrial Pattern and Sub-endometrial Vascularity in ICSI Outcome
|
||
Recruiting |
NCT03161119 -
Comparing Two Different Embryo Transfer Catheters
|
N/A | |
Completed |
NCT04108039 -
Micronized Progesterone vs Gonadotropin-releasing Hormone (GnRH) Antagonist in Freeze-all IVF Cycles.
|
N/A | |
Completed |
NCT03678818 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Latrunculin A (ICSI-LA)
|
N/A | |
Completed |
NCT03677492 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Cytochalasin D ( ICSI-CD)
|
N/A | |
Completed |
NCT03678584 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Chaetoglobosin A ( ICSI-CA)
|
N/A | |
Completed |
NCT03678558 -
Oocyte Vitrification Aided With Cytochalasin B
|
N/A | |
Completed |
NCT03678610 -
Handling Medium for ICSI With Ionomycin and Latrunculin A
|
N/A | |
Completed |
NCT03678571 -
Oocyte Vitrification Aided With Latrunculin A
|
N/A | |
Completed |
NCT03678597 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Latrunculin B ( ICSI-LB)
|
N/A |